miércoles, 1 de abril de 2020

Have you seen the latest news and insights on Cystic Fibrosis News Today?


Cystic Fibrosis Weekly Update

Contents:

MRT5005 Gets FDA Rare Pediatric Disease Status as Adult Trial Faces Delay Due to COVID-19

Apr 01, 2020 07:00 am | David Melamed, PhD



rare pediatric status, MRT5005Translate Bio‘s therapy MRT5005 has been given a rare pediatric disease designation by the U.S. Food and Drug Administration (FDA) for the treatment of cystic fibrosis in children, while its ongoing clinical trial investigating the therapy in adult patients faces delays due to the COVID-19 pandemic, the company has announced. The designation is given to […]
The post MRT5005 Gets FDA Rare Pediatric Disease Status as Adult Trial Faces Delay Due to COVID-19 appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike MRT5005 Gets FDA Rare Pediatric Disease Status as Adult Trial Faces Delay Due to COVID-19 on Facebook

I’m Holding a Funeral for My Former Self

Mar 31, 2020 03:00 pm | Bailey Vincent



perspectiveI am at a loss with loss. Yesterday, I lost my last remaining telecommuting job, my dance company (in the sense that we are now on a long-term hiatus), our show that was only weeks away (and has now been postponed), my keys, and my mind. If you’re like me, you’re sick of seeing sickness […]
The post I’m Holding a Funeral for My Former Self appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike I’m Holding a Funeral for My Former Self on Facebook

Vertex Assures Supply of CF Therapies, But COVID-19 Likely to Affect Trials

Mar 31, 2020 07:00 am | Mary Chapman



Vertex and Covid-19Vertex Pharmaceuticals is “highly confident” that it can continue to supply its approved cystic fibrosis (CF) therapies to patients worldwide, but expects at least some of its ongoing and planned clinical trials to be affected by the COVID-19 pandemic. Among likely changes to ongoing trials well into the dosing of patients — including a Phase 3 study of the recently approved […]
The post Vertex Assures Supply of CF Therapies, But COVID-19 Likely to Affect Trials appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Vertex Assures Supply of CF Therapies, But COVID-19 Likely to Affect Trials on Facebook

Trikafta Therapy Prompted the Most Unexpected Emotions

Mar 30, 2020 03:00 pm | Wendy Caroline



covid-19The excitement and flurry around the new combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) brought a lot of hope to the CF community. This is a good thing. However, many complex emotions are not being addressed. Everyone expects a flood of challenging emotions when one transitions from healthy to dying, but what about the other way around? How […]
The post Trikafta Therapy Prompted the Most Unexpected Emotions appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Trikafta Therapy Prompted the Most Unexpected Emotions on Facebook

Recent News

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others
Eloxx Pauses Phase 2 Trials of ELX-02 in Cystic Fibrosis Due to COVID-19
I’m Worried About Coughing in Public
NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum
Problems with CFTR Protein in Platelets Linked to Lung Inflammation, Injury

No hay comentarios:

Publicar un comentario